Xiarou Liu

Title: The Innovative Contributions of Xiarou Liu in Pharmaceutical Research

Introduction

Xiarou Liu is a notable inventor based in Shenzhen, China, recognized for his contributions to the pharmaceutical field. With one patent to his name, Liu showcases a deep commitment to innovation in drug development, particularly in enhancing the composition and stability of pharmaceutical compounds.

Latest Patents

Liu's most recent patent involves the "Crystal form of neptinib di-p-methylbenzenesulfonate, preparation method thereof, and pharmaceutical composition containing same." This patent presents a stable α-polymorph of a complex compound known as N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(ethoxy)-6-quinazolinyl]-4-(dimethylamino)-2-butenamide p-toluene sulfonate 1.5 hydrate. The α-polymorph exhibits a defined melting point, impressive chemical stability, and excellent resistance to high temperatures and light irradiation, making it highly suitable for pharmaceutical applications.

Career Highlights

Xiarou Liu is currently working at the Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd., where he continues to drive innovation in pharmaceutical research. His role at the institute has positioned him as a key player in the development of stable and effective drug compositions, enhancing the potential for clinical applications.

Collaborations

Throughout his career, Liu has worked alongside talented colleagues such as Tian Tang and Feng Jin. These collaborations emphasize a strong team dynamic within the Shenzhen Neptunus Pharmaceutical Research Institute, fostering a creative environment for innovative research.

Conclusion

In summary, Xiarou Liu stands out in the pharmaceutical community for his significant contributions, particularly through his new patent that improves the stability and usability of pharmaceutical compositions. His work reflects the ongoing pursuit of innovation in drug development, promising advancements that may benefit the healthcare sector in the near future.